- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Human Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Human Vaccine market size is estimated to be worth US$ 32870 million in 2021 and is forecast to a readjusted size of USD 44570 million by 2028 with a CAGR of 4.4% during review period. Adults accounting for % of the Human Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Varicella segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Vaccine include CNBG, Changsheng Life, Zhifei, ChengDa Bio, and Kangtai, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Market segment by Application can be divided into
Adults
Children
The key market players for global Human Vaccine market are listed below:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Vaccine, with price, sales, revenue and global market share of Human Vaccine from 2019 to 2022.
Chapter 3, the Human Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Vaccine.
Chapter 13, 14, and 15, to describe Human Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Human Vaccine Market Size & Forecast
1.4.1 Global Human Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Vaccine Sales in Volume (2017-2028)
1.4.3 Global Human Vaccine Price (2017-2028)
1.5 Global Human Vaccine Production Capacity Analysis
1.5.1 Global Human Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Human Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Vaccine Market Drivers
1.6.2 Human Vaccine Market Restraints
1.6.3 Human Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 CNBG
2.1.1 CNBG Details
2.1.2 CNBG Major Business
2.1.3 CNBG Human Vaccine Product and Services
2.1.4 CNBG Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Changsheng Life
2.2.1 Changsheng Life Details
2.2.2 Changsheng Life Major Business
2.2.3 Changsheng Life Human Vaccine Product and Services
2.2.4 Changsheng Life Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zhifei
2.3.1 Zhifei Details
2.3.2 Zhifei Major Business
2.3.3 Zhifei Human Vaccine Product and Services
2.3.4 Zhifei Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 ChengDa Bio
2.4.1 ChengDa Bio Details
2.4.2 ChengDa Bio Major Business
2.4.3 ChengDa Bio Human Vaccine Product and Services
2.4.4 ChengDa Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kangtai
2.5.1 Kangtai Details
2.5.2 Kangtai Major Business
2.5.3 Kangtai Human Vaccine Product and Services
2.5.4 Kangtai Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 SINOVAC BIOTECH
2.6.1 SINOVAC BIOTECH Details
2.6.2 SINOVAC BIOTECH Major Business
2.6.3 SINOVAC BIOTECH Human Vaccine Product and Services
2.6.4 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hissen
2.7.1 Hissen Details
2.7.2 Hissen Major Business
2.7.3 Hissen Human Vaccine Product and Services
2.7.4 Hissen Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Walvax Biotechnology
2.8.1 Walvax Biotechnology Details
2.8.2 Walvax Biotechnology Major Business
2.8.3 Walvax Biotechnology Human Vaccine Product and Services
2.8.4 Walvax Biotechnology Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Human Vaccine Product and Services
2.9.4 GSK Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 SANOFI
2.10.1 SANOFI Details
2.10.2 SANOFI Major Business
2.10.3 SANOFI Human Vaccine Product and Services
2.10.4 SANOFI Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Rong An
2.11.1 Rong An Details
2.11.2 Rong An Major Business
2.11.3 Rong An Human Vaccine Product and Services
2.11.4 Rong An Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 NuoCheng Bio
2.12.1 NuoCheng Bio Details
2.12.2 NuoCheng Bio Major Business
2.12.3 NuoCheng Bio Human Vaccine Product and Services
2.12.4 NuoCheng Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Human Vaccine Product and Services
2.13.4 Hualan Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Tiantan biological
2.14.1 Tiantan biological Details
2.14.2 Tiantan biological Major Business
2.14.3 Tiantan biological Human Vaccine Product and Services
2.14.4 Tiantan biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Changchun Baike
2.15.1 Changchun Baike Details
2.15.2 Changchun Baike Major Business
2.15.3 Changchun Baike Human Vaccine Product and Services
2.15.4 Changchun Baike Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Adimmune
2.16.1 Adimmune Details
2.16.2 Adimmune Major Business
2.16.3 Adimmune Human Vaccine Product and Services
2.16.4 Adimmune Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Zhongyianke Biotech
2.17.1 Zhongyianke Biotech Details
2.17.2 Zhongyianke Biotech Major Business
2.17.3 Zhongyianke Biotech Human Vaccine Product and Services
2.17.4 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Bharat Biotech
2.18.1 Bharat Biotech Details
2.18.2 Bharat Biotech Major Business
2.18.3 Bharat Biotech Human Vaccine Product and Services
2.18.4 Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Bavarian Nordic
2.19.1 Bavarian Nordic Details
2.19.2 Bavarian Nordic Major Business
2.19.3 Bavarian Nordic Human Vaccine Product and Services
2.19.4 Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Sanofi-Pasteur
2.20.1 Sanofi-Pasteur Details
2.20.2 Sanofi-Pasteur Major Business
2.20.3 Sanofi-Pasteur Human Vaccine Product and Services
2.20.4 Sanofi-Pasteur Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Indian Immunologicals
2.21.1 Indian Immunologicals Details
2.21.2 Indian Immunologicals Major Business
2.21.3 Indian Immunologicals Human Vaccine Product and Services
2.21.4 Indian Immunologicals Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 KANGH
2.22.1 KANGH Details
2.22.2 KANGH Major Business
2.22.3 KANGH Human Vaccine Product and Services
2.22.4 KANGH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Henan Grand Biopharma
2.23.1 Henan Grand Biopharma Details
2.23.2 Henan Grand Biopharma Major Business
2.23.3 Henan Grand Biopharma Human Vaccine Product and Services
2.23.4 Henan Grand Biopharma Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 ZhongKe Biopharm
2.24.1 ZhongKe Biopharm Details
2.24.2 ZhongKe Biopharm Major Business
2.24.3 ZhongKe Biopharm Human Vaccine Product and Services
2.24.4 ZhongKe Biopharm Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 Zhuoyi Biological
2.25.1 Zhuoyi Biological Details
2.25.2 Zhuoyi Biological Major Business
2.25.3 Zhuoyi Biological Human Vaccine Product and Services
2.25.4 Zhuoyi Biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Vaccine Breakdown Data by Manufacturer
3.1 Global Human Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Human Vaccine Manufacturer Market Share in 2021
3.5 Global Human Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Vaccine Market Size by Region
4.1.1 Global Human Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Human Vaccine Revenue by Region (2017-2028)
4.2 North America Human Vaccine Revenue (2017-2028)
4.3 Europe Human Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Human Vaccine Revenue (2017-2028)
4.5 South America Human Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Human Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Human Vaccine Revenue by Type (2017-2028)
5.3 Global Human Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Human Vaccine Revenue by Application (2017-2028)
6.3 Global Human Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Vaccine Sales by Type (2017-2028)
7.2 North America Human Vaccine Sales by Application (2017-2028)
7.3 North America Human Vaccine Market Size by Country
7.3.1 North America Human Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Human Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Vaccine Sales by Type (2017-2028)
8.2 Europe Human Vaccine Sales by Application (2017-2028)
8.3 Europe Human Vaccine Market Size by Country
8.3.1 Europe Human Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Human Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Human Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Vaccine Sales by Type (2017-2028)
10.2 South America Human Vaccine Sales by Application (2017-2028)
10.3 South America Human Vaccine Market Size by Country
10.3.1 South America Human Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Human Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Human Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Human Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Vaccine
12.3 Human Vaccine Production Process
12.4 Human Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Vaccine Typical Distributors
13.3 Human Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Human Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. CNBG Basic Information, Manufacturing Base and Competitors
Table 4. CNBG Major Business
Table 5. CNBG Human Vaccine Product and Services
Table 6. CNBG Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Changsheng Life Basic Information, Manufacturing Base and Competitors
Table 8. Changsheng Life Major Business
Table 9. Changsheng Life Human Vaccine Product and Services
Table 10. Changsheng Life Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zhifei Basic Information, Manufacturing Base and Competitors
Table 12. Zhifei Major Business
Table 13. Zhifei Human Vaccine Product and Services
Table 14. Zhifei Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table 16. ChengDa Bio Major Business
Table 17. ChengDa Bio Human Vaccine Product and Services
Table 18. ChengDa Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Kangtai Basic Information, Manufacturing Base and Competitors
Table 20. Kangtai Major Business
Table 21. Kangtai Human Vaccine Product and Services
Table 22. Kangtai Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table 24. SINOVAC BIOTECH Major Business
Table 25. SINOVAC BIOTECH Human Vaccine Product and Services
Table 26. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Hissen Basic Information, Manufacturing Base and Competitors
Table 28. Hissen Major Business
Table 29. Hissen Human Vaccine Product and Services
Table 30. Hissen Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 32. Walvax Biotechnology Major Business
Table 33. Walvax Biotechnology Human Vaccine Product and Services
Table 34. Walvax Biotechnology Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GSK Basic Information, Manufacturing Base and Competitors
Table 36. GSK Major Business
Table 37. GSK Human Vaccine Product and Services
Table 38. GSK Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. SANOFI Basic Information, Manufacturing Base and Competitors
Table 40. SANOFI Major Business
Table 41. SANOFI Human Vaccine Product and Services
Table 42. SANOFI Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Rong An Basic Information, Manufacturing Base and Competitors
Table 44. Rong An Major Business
Table 45. Rong An Human Vaccine Product and Services
Table 46. Rong An Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table 48. NuoCheng Bio Major Business
Table 49. NuoCheng Bio Human Vaccine Product and Services
Table 50. NuoCheng Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 52. Hualan Bio Major Business
Table 53. Hualan Bio Human Vaccine Product and Services
Table 54. Hualan Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Tiantan biological Basic Information, Manufacturing Base and Competitors
Table 56. Tiantan biological Major Business
Table 57. Tiantan biological Human Vaccine Product and Services
Table 58. Tiantan biological Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Changchun Baike Basic Information, Manufacturing Base and Competitors
Table 60. Changchun Baike Major Business
Table 61. Changchun Baike Human Vaccine Product and Services
Table 62. Changchun Baike Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Adimmune Basic Information, Manufacturing Base and Competitors
Table 64. Adimmune Major Business
Table 65. Adimmune Human Vaccine Product and Services
Table 66. Adimmune Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Zhongyianke Biotech Major Business
Table 69. Zhongyianke Biotech Human Vaccine Product and Services
Table 70. Zhongyianke Biotech Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Bharat Biotech Major Business
Table 73. Bharat Biotech Human Vaccine Product and Services
Table 74. Bharat Biotech Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 76. Bavarian Nordic Major Business
Table 77. Bavarian Nordic Human Vaccine Product and Services
Table 78. Bavarian Nordic Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi-Pasteur Major Business
Table 81. Sanofi-Pasteur Human Vaccine Product and Services
Table 82. Sanofi-Pasteur Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 84. Indian Immunologicals Major Business
Table 85. Indian Immunologicals Human Vaccine Product and Services
Table 86. Indian Immunologicals Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 87. KANGH Basic Information, Manufacturing Base and Competitors
Table 88. KANGH Major Business
Table 89. KANGH Human Vaccine Product and Services
Table 90. KANGH Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 91. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
Table 92. Henan Grand Biopharma Major Business
Table 93. Henan Grand Biopharma Human Vaccine Product and Services
Table 94. Henan Grand Biopharma Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 95. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
Table 96. ZhongKe Biopharm Major Business
Table 97. ZhongKe Biopharm Human Vaccine Product and Services
Table 98. ZhongKe Biopharm Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 99. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 100. Zhuoyi Biological Major Business
Table 101. Zhuoyi Biological Human Vaccine Product and Services
Table 102. Zhuoyi Biological Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 103. Global Human Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 104. Global Human Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 105. Market Position of Manufacturers in Human Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 106. Global Human Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 107. Head Office and Human Vaccine Production Site of Key Manufacturer
Table 108. Human Vaccine New Entrant and Capacity Expansion Plans
Table 109. Human Vaccine Mergers & Acquisitions in the Past Five Years
Table 110. Global Human Vaccine Sales by Region (2017-2022) & (M Doses)
Table 111. Global Human Vaccine Sales by Region (2023-2028) & (M Doses)
Table 112. Global Human Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 113. Global Human Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 114. Global Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 115. Global Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 116. Global Human Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 117. Global Human Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 118. Global Human Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 119. Global Human Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 120. Global Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 121. Global Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 122. Global Human Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 123. Global Human Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 124. Global Human Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 125. Global Human Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 126. North America Human Vaccine Sales by Country (2017-2022) & (M Doses)
Table 127. North America Human Vaccine Sales by Country (2023-2028) & (M Doses)
Table 128. North America Human Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 129. North America Human Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 130. North America Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 131. North America Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 132. North America Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 133. North America Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 134. Europe Human Vaccine Sales by Country (2017-2022) & (M Doses)
Table 135. Europe Human Vaccine Sales by Country (2023-2028) & (M Doses)
Table 136. Europe Human Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 137. Europe Human Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 138. Europe Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 139. Europe Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 140. Europe Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 141. Europe Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 142. Asia-Pacific Human Vaccine Sales by Region (2017-2022) & (M Doses)
Table 143. Asia-Pacific Human Vaccine Sales by Region (2023-2028) & (M Doses)
Table 144. Asia-Pacific Human Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 145. Asia-Pacific Human Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 146. Asia-Pacific Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 147. Asia-Pacific Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 148. Asia-Pacific Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 149. Asia-Pacific Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 150. South America Human Vaccine Sales by Country (2017-2022) & (M Doses)
Table 151. South America Human Vaccine Sales by Country (2023-2028) & (M Doses)
Table 152. South America Human Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 153. South America Human Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 154. South America Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 155. South America Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 156. South America Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 157. South America Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 158. Middle East & Africa Human Vaccine Sales by Region (2017-2022) & (M Doses)
Table 159. Middle East & Africa Human Vaccine Sales by Region (2023-2028) & (M Doses)
Table 160. Middle East & Africa Human Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 161. Middle East & Africa Human Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 162. Middle East & Africa Human Vaccine Sales by Type (2017-2022) & (M Doses)
Table 163. Middle East & Africa Human Vaccine Sales by Type (2023-2028) & (M Doses)
Table 164. Middle East & Africa Human Vaccine Sales by Application (2017-2022) & (M Doses)
Table 165. Middle East & Africa Human Vaccine Sales by Application (2023-2028) & (M Doses)
Table 166. Human Vaccine Raw Material
Table 167. Key Manufacturers of Human Vaccine Raw Materials
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. Human Vaccine Typical Distributors
Table 171. Human Vaccine Typical Customers
List of Figures
Figure 1. Human Vaccine Picture
Figure 2. Global Human Vaccine Revenue Market Share by Type in 2021
Figure 3. Varicella
Figure 4. Influenza
Figure 5. Polio
Figure 6. Hepatitis A
Figure 7. Rabies
Figure 8. BCG
Figure 9. Hepatitis B
Figure 10. Pertussis, Diphtheria, Tetanus
Figure 11. Pneumococcal
Figure 12. Rota vaccine
Figure 13. Global Human Vaccine Revenue Market Share by Application in 2021
Figure 14. Adults
Figure 15. Children
Figure 16. Global Human Vaccine Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 17. Global Human Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Human Vaccine Sales (2017-2028) & (M Doses)
Figure 19. Global Human Vaccine Price (2017-2028) & (USD/Dose)
Figure 20. Global Human Vaccine Production Capacity (2017-2028) & (M Doses)
Figure 21. Global Human Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Human Vaccine Market Drivers
Figure 23. Human Vaccine Market Restraints
Figure 24. Human Vaccine Market Trends
Figure 25. Global Human Vaccine Sales Market Share by Manufacturer in 2021
Figure 26. Global Human Vaccine Revenue Market Share by Manufacturer in 2021
Figure 27. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Human Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Human Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Human Vaccine Sales Market Share by Region (2017-2028)
Figure 31. Global Human Vaccine Revenue Market Share by Region (2017-2028)
Figure 32. North America Human Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. Europe Human Vaccine Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Human Vaccine Revenue (2017-2028) & (USD Million)
Figure 35. South America Human Vaccine Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Human Vaccine Revenue (2017-2028) & (USD Million)
Figure 37. Global Human Vaccine Sales Market Share by Type (2017-2028)
Figure 38. Global Human Vaccine Revenue Market Share by Type (2017-2028)
Figure 39. Global Human Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 40. Global Human Vaccine Sales Market Share by Application (2017-2028)
Figure 41. Global Human Vaccine Revenue Market Share by Application (2017-2028)
Figure 42. Global Human Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 43. North America Human Vaccine Sales Market Share by Type (2017-2028)
Figure 44. North America Human Vaccine Sales Market Share by Application (2017-2028)
Figure 45. North America Human Vaccine Sales Market Share by Country (2017-2028)
Figure 46. North America Human Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. United States Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Human Vaccine Sales Market Share by Type (2017-2028)
Figure 51. Europe Human Vaccine Sales Market Share by Application (2017-2028)
Figure 52. Europe Human Vaccine Sales Market Share by Country (2017-2028)
Figure 53. Europe Human Vaccine Revenue Market Share by Country (2017-2028)
Figure 54. Germany Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Human Vaccine Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Human Vaccine Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Human Vaccine Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Human Vaccine Revenue Market Share by Region (2017-2028)
Figure 63. China Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Human Vaccine Sales Market Share by Type (2017-2028)
Figure 70. South America Human Vaccine Sales Market Share by Application (2017-2028)
Figure 71. South America Human Vaccine Sales Market Share by Country (2017-2028)
Figure 72. South America Human Vaccine Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Human Vaccine Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Human Vaccine Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Human Vaccine Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Human Vaccine Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Human Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Human Vaccine in 2021
Figure 84. Manufacturing Process Analysis of Human Vaccine
Figure 85. Human Vaccine Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
